Anti-PD-L1 hIgG1 (N298A) | Atezolizumab Biosimilar Antibody,Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy | Molecular Cancer | Full Text,Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy | Molecular Cancer | Full Text,Current and Future Perspectives of PDL1 PET and SPECT Imaging - ScienceDirect,Inside PD-1/PD-L1,2 with their inhibitors - ScienceDirect